Passa al contenuto
Merck

Myrtenal inhibits acetylcholinesterase, a known Alzheimer target.

The Journal of pharmacy and pharmacology (2011-09-09)
Dorothea Kaufmann, Anudeep Kaur Dogra, Michael Wink
ABSTRACT

Inhibition of acetylcholinesterase (AChE) is a common treatment for early stages of the most general form of dementia, Alzheimer's disease. In this study selected components of essential oils, which carry a variety of important functional groups, were tested for their in-vitro anti-acetylcholinesterase activity. In-vitro anti-acetylcholinesterase activity was measured by an adapted version of Ellman's colorimetric assay. 1,8-cineole, carvacrol, myrtenal and verbenone apparently inhibited AChE; the highest inhibitory activity was observed for myrtenal (IC50 = 0.17 mm). This is the first study showing the AChE inhibitory activity of myrtenal. Our investigations provided evidence for the efficacy of monoterpenes as inhibitors of AChE.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
(1S)-(−)-Verbenone, ≥93%
Sigma-Aldrich
(1S)-(−)-Verbenone, 94%
Supelco
(1S)-(−)-Verbenone, analytical standard